Tech Company Financing Transactions

Pattern Bioscience Funding Round

On 4/27/2023, Pattern Bioscience raised $28.7 million in Series C financing from Illumina Ventures, Omnimed Capital and AMR Action Fund.

Transaction Overview

Company Name
Announced On
4/27/2023
Transaction Type
Venture Equity
Amount
$28,700,000
Round
Series C
Investors

Illumina Ventures (Lead Investor) (Nick Naclerio)

Omnimed Capital (Lead Investor)

AMR Action Fund

Daleshaw

Proceeds Purpose
The company intends to use the funds to complete the development of its rapid phenotypic test platform for infectious diseases, perform clinical validation studies, and submit the platform and its initial pneumonia test for regulatory review with the U.S. Food and Drug Administration (FDA).

Company Information

Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
9600 Great Hills Trail 160E
Austin, TX 78759
USA
Phone
Undisclosed
Email Address
Overview
Our mission is simple: We will improve the world's most important health decisions. Whether you call them superbugs, pan-resistant organisms, or just plain deadly, drug-resistant microbes have become a global public health crisis. Pattern is a clinical diagnostics company dedicated to bringing experience, innovation and technology to the fight against antibiotic resistance.
Profile
Pattern Bioscience LinkedIn Company Profile
Social Media
Pattern Bioscience Company Twitter Account
Company News
Pattern Bioscience News
Facebook
Pattern Bioscience on Facebook
YouTube
Pattern Bioscience on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Nick Arab
  Nick Arab LinkedIn Profile  Nick Arab Twitter Account  Nick Arab News  Nick Arab on Facebook
VP - Bus. Development
Kyle Fieleke
  Kyle Fieleke LinkedIn Profile  Kyle Fieleke Twitter Account  Kyle Fieleke News  Kyle Fieleke on Facebook
VP - Engineering
Ross Johnson
  Ross Johnson LinkedIn Profile  Ross Johnson Twitter Account  Ross Johnson News  Ross Johnson on Facebook
VP - Human Resources
Cindy Lopez
  Cindy Lopez LinkedIn Profile  Cindy Lopez Twitter Account  Cindy Lopez News  Cindy Lopez on Facebook
VP - R & D
David Bussian
  David Bussian LinkedIn Profile  David Bussian Twitter Account  David Bussian News  David Bussian on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/27/2023: Lasso MD venture capital transaction
Next: 4/27/2023: Bastion Technologies venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary